Several checkpoint proteins, such as CTLA-4, PD-1, TIM-3 and LAG-3, have been identified as regulatory molecules suppressing an effective patient-inherent immune defense of cancer, mainly by T cells. The gene discussed is HAVCR2; the disease is cancer.